Dopamine News and Research

Latest Dopamine News and Research

Smoking cessation drug shows potential to treat Parkinson's disease in females

Texas A&M University College of Medicine ressearchers have recently discovered that cytisine -- a smoking cessation drug commonly used in Europe -- reduces the loss of dopamine neurons in females. These findings provide potential evidence for the use of the drug to treat Parkinson's disease or stop its progression in women.

4 Mar 2021

Researchers discover new ingredient that has protective effects against Parkinson’s disease

Sesame seed oil, used by many for its nutty aroma and high burn-point, is made by extracting the fatty oils from sesame seeds, with the empty shells thrown out as waste. In a literal instantiation of the age-old adage "one man's trash is another man's treasure", researchers discovered that a chemical called sesaminol, abundant in this waste, has protective effects against Parkinson's disease.

2 Mar 2021

Study reveals information about risk genes in schizophrenia

Dr. Felix-Martin Werner, working at the Euro Academy Pößneck in Germany and Prof. Rafael Coveñas, working at the Institute of Neurosciences of Castilla and León, Salamanca in Spain, have been working on neurological and psychiatric disease for over ten years.

26 Feb 2021

In Vivo Probes for Detecting Inflammation Markers in Humans and Animals

News-Medical talks to Parry Hashemi about research on in vivo probes for detecting inflammation markers in humans and animals she will present at Pittcon.

From Pittcon 24 Feb 2021

Researchers find new way to enhance the sensitivity of electrochemical micro-sensors

A team led by researchers at the New York University Tandon School of Engineering have found a new way of enhancing the performance of electrochemical micro-sensors.

20 Feb 2021

Study explains why antipsychotic medications lead to weight gain, promote metabolic syndrome

Why do patients who receive antipsychotic medications to manage schizophrenia and bipolar disorder quickly gain weight and develop prediabetes and hyperinsulemia?

15 Feb 2021

Star-shaped brain cells may play a key role in stuttering

Astrocytes -- star-shaped cells in the brain that are actively involved in brain function -- may play an important role in stuttering, a study led by a University of California, Riverside, expert on stuttering has found.

12 Feb 2021

Study unravels function of 'mystery protein' that kills brain cells of people with Parkinson's

A study published in Nature Communications today (Wednesday 10 February) presents compelling new evidence about what a key protein called alpha-synuclein actually does in neurons in the brain.

10 Feb 2021

Modified lipids target the body’s endocannabinoid system to regulate pain and inflammation

When modified using a process known as epoxidation, two naturally occurring lipids are converted into potent agents that target multiple cannabinoid receptors in neurons, interrupting pathways that promote pain and inflammation, researchers report.

10 Feb 2021

New combination treatment approach improves overall survival in mice with glioblastoma

In a study of mice, researchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new approach that combines an anti-psychotic drug, a statin used to lower high cholesterol levels, and radiation to improve the overall survival in mice with glioblastoma.

9 Feb 2021

Imaging technique can differentiate Alzheimer's disease from dementia with Lewy bodies

Scientists in Portugal and the United Kingdom were able to confirm that an imaging technique that traces neuronal dopaminergic deficiency in the brain is able to differentiate, in vivo, Alzheimer's disease from lesser-known dementia with Lewy bodies.

5 Feb 2021

Spontaneous eye blink rate could help understand the link between fitness and cognitive function

Although exercise is known to enhance cognitive function and improve mental health, the neurological mechanisms of this link are unknown. Now, researchers from Japan have found evidence of the missing link between aerobic fitness and cognitive function.

4 Feb 2021

Scientists unravel the workings of a mysterious protein implicated in movement disorders

Scientists at Scripps Research have clarified the workings of a mysterious protein called Gαo, which is one of the most abundant proteins in the brain and, when mutated, causes severe movement disorders.

3 Feb 2021

Scientists discover mechanism for transient memory lapse

In a landmark neurobiology study, scientists from Scripps Research have discovered a memory gating system that employs the neurotransmitter dopamine to direct transient forgetting, a temporary lapse of memory which spontaneously returns.

21 Jan 2021

BMP5/7 protein offers promising therapeutics that could halt the progression of Parkinson's disease

Ben-Gurion University of the Negev researchers have discovered that the protein BMP5/7 offers promising therapeutics that could slow down or halt the progression of Parkinson's disease.

20 Jan 2021

Simple vision tests can predict Parkinson's dementia before it begins

Simple vision tests can predict which people with Parkinson's disease will develop cognitive impairment and possible dementia 18 months later, according to a new study by UCL researchers.

19 Jan 2021

Researchers find potential biomarkers of Parkinson's disease

A research team led by Nagoya University in Japan has found that blood pressure, the hematocrit (the percentage of red blood cells in blood), and serum cholesterol levels change in patients with Parkinson's disease long before the onset of motor symptoms.

18 Jan 2021

Patients with schizophrenia have increased risk of Parkinson's disease, shows study

A new study conducted at the University of Turku, Finland, shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson's disease later in life.

15 Jan 2021

Defective metabolism of Parkinson’s drug is linked to adverse side effects

Until now, the reason why the drug levodopa (L-Dopa), which reduces the motor symptoms of Parkinson's disease, declines in efficacy after a few years' use has been unknown.

7 Jan 2021

Repeated ketamine infusions may be a promising treatment for PTSD patients

Repeated intravenous (IV) ketamine infusions significantly reduce symptom severity in individuals with chronic post-traumatic stress disorder (PTSD) and the improvement is rapid and maintained for several weeks afterwards, according to a study conducted by researchers from the Icahn School of Medicine at Mount Sinai.

5 Jan 2021

Dopamine News and Research

Latest Dopamine News and Research

Smoking cessation drug shows potential to treat Parkinson's disease in females

Researchers discover new ingredient that has protective effects against Parkinson’s disease

Study reveals information about risk genes in schizophrenia

In Vivo Probes for Detecting Inflammation Markers in Humans and Animals

Researchers find new way to enhance the sensitivity of electrochemical micro-sensors

Study explains why antipsychotic medications lead to weight gain, promote metabolic syndrome

Star-shaped brain cells may play a key role in stuttering

Study unravels function of 'mystery protein' that kills brain cells of people with Parkinson's

Modified lipids target the body’s endocannabinoid system to regulate pain and inflammation

New combination treatment approach improves overall survival in mice with glioblastoma

Imaging technique can differentiate Alzheimer's disease from dementia with Lewy bodies

Spontaneous eye blink rate could help understand the link between fitness and cognitive function

Scientists unravel the workings of a mysterious protein implicated in movement disorders

Scientists discover mechanism for transient memory lapse

BMP5/7 protein offers promising therapeutics that could halt the progression of Parkinson's disease

Simple vision tests can predict Parkinson's dementia before it begins

Researchers find potential biomarkers of Parkinson's disease

Patients with schizophrenia have increased risk of Parkinson's disease, shows study

Defective metabolism of Parkinson’s drug is linked to adverse side effects

Repeated ketamine infusions may be a promising treatment for PTSD patients

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Dopamine News and Research

Latest Dopamine News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Newsletters you may be interested in